Brazil Diagnostic Labs Market By Provider Type (Hospital Based Diagnostic Labs, Diagnostic Chains, Stand Alone Diagnostic Labs), By Test Type (Pathology, Radiology), By End User (Walk-ins, Referrals, Corporate Clients), By Region, Competition, Forecast &

Brazil Diagnostic Labs Market By Provider Type (Hospital Based Diagnostic Labs, Diagnostic Chains, Stand Alone Diagnostic Labs), By Test Type (Pathology, Radiology), By End User (Walk-ins, Referrals, Corporate Clients), By Region, Competition, Forecast & Opportunities, 2018-2028F

Brazil Diagnostic Labs Market is anticipated to witness a growth of steady CAGR in the forecast period, 2024-2028. This can be ascribed to the rising prevalence of various chronic diseases such as cancer, cardiovascular diseases, and diabetes, among others. According to the global cancer observatory, in 2020, around 592,212 new cancer cases were reported in Brazil, out of which 300,114 new cancer cases were reported in males, while the number of new cancer cases reported in females was around 292,098. Prostate Cancer, Breast Cancer, Colorectum Cancer, Lung Cancer, and Thyroid Cancer are the five most prevalent types of cancer in Brazil. Besides, the growing geriatric population in the country is further expected to support market growth. The geriatric population is susceptible to various kinds of communicable and non-communicable diseases, as a result of which the demand for different diagnostic procedures has significantly risen, thereby driving the growth of Brazil Diagnostic Labs Market.

Diagnostic tests form the fundamental component of the concept of health services. They are the inseparable essential step towards guiding patient care.

Mandated Access Helps the Brazilian Healthcare Industry

The healthcare system in Brazil covers universal health strategies in which the private health sector market is much more relevant as it covers more than the public health sector. The country has a national health system, the Unified Health System (SUS), established as a part of the 1988 federal constitution. The health system is financed through public funds and employee/employer contributions to the National Social Security System (INSS). The SUS provides access to Brazilians via a mix of public and private providers, out of which approximately 77 % of the population utilizes the SUS totally, whereas the rest 23% also has additional supplementary health schemes provided by the insurance companies and health scheme providers. However, since the SUS has been unable to reach Brazil’s entire population of 192 million, private health plans have become increasingly popular and offered as services through private insurance policies. According to the statistics, the spread of private insurance among the total Brazilian population raised from 19.9% to 23.2% in 2018. This rise in insured public proportionally raises the use of diagnostic services and labs, thereby supporting the growth of Brazil Diagnostic Labs Market.

Growing Number of Independent Labs and Clinical Chains

The presence of a significant number of independent labs and clinical chains has strengthened the health services availability in distinct regions of Brazil and thereby driving the diagnostic labs market growth. Public health laboratories are organized in the National System of Public Health Laboratories (SISLAB), a set of national laboratory networks for activities covering health, epidemiological and environmental surveillance, and medical care. Each network is under the responsibility of a government agency.

According to the National Registry of Health Facilities in the Ministry of Health (CNES/MS), by the end of June 2020, there were around 24,760 Therapeutic Diagnosis Support Services (SADTs) in Brazil. In the country, there is at least one SADT unit for 3,466 cities, with respect to 62% of municipalities therein operating within hospitals, clinics, and other health facilities. Most of these are provided by private organizations, and a small proportion by the public sector.

Frequency of Tests and Assessments for Monitoring Individuals with Diabetes

According to a report published by the Brazilian Society of Diabetes (Sociedade Brasileira de Diabetes - SBD), in 2021, the incidence of diabetes in Brazil was 7.6% of the population (approximately 16 million people). Brazil holds the fifth position in the number of diabetes cases after China, India, the United States, and Pakistan. Diabetes is the third leading cause of mortality in the country, with cardiovascular diseases and cancer being number one and two, respectively. This, in turn, creates the need for diagnosing and doing regular monitoring for diabetes in the country, thereby fostering the growth of Brazil Diagnostic Labs Market.

Recent Developments

According to a report published in 2019, DASA Labs, the biggest diagnostic company in Brazil, made a step towards integrating health care by investing in the acquisition of hospitals. After the Rede D’Or acquisition, it became the second-largest hospital group in the country. Similarly, Fleury recently merged with Hermes Pardini, another leader in Brazil diagnostics. Meanwhile, Fleury, along with integrated healthcare, has also acquired medical clinics. All these strategies followed by key players operating in the industry, such as mergers & acquisitions, collaborations & partnerships, investments, and expansions, not only help them in staying competitive and have an edge over other players operating in the market but also support the growth of Brazil diagnostic labs market.

Rising Geriatric Population

Brazil holds 6th position among the world’s most populated countries after China, India, the United States, Indonesia, and Pakistan. The country has been going through an expeditious demographic change, with near about 10% of the aged population over 65 years. The growing aging population in Brazil is estimated to experience enormous growth as the country’s population is supposed to shift the aging population of 45 and older is predicted to represent 52% of the total by 2050 versus 33% in 2020.

The increasing disease prevalence among the aged population makes them more dependent on diagnostic labs every now and then and thereby boosting the market growth.

Market Segmentation

Brazil Diagnostic Labs Market is segmented into Provider Type, test type, end users, and region. Based on product type, the market can be segmented into Hospital Based Diagnostic Labs, Diagnostic Chains, and Stand-Alone Diagnostic Labs. Depending on the Test type, the market can be segmented into Pathology and Radiology. Based on end users, the market can be differentiated into Walk-ins, Referrals, and Corporate Clients.

Market Players

DASA labs, Quest Diagnostics Incorporated, SYNLAB-Solutions in Diagnostics, Grupo Fleury, Hospital Israelita Albert Einstein, Alliar, Boris Berenstein Diagnostic Center, Clinica da Imagem do Tocantis, Abramed, and Hermes Pardini, etc. are some of the leading players operating in the Brazil Diagnostic Labs Market.

Report Scope:

In this report, the global Brazil Diagnostic Labs Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

• Brazil Diagnostic Labs Market, By Provider Type:
• Hospital Based Diagnostic Labs
• Diagnostic Chains
• Stand Alone Diagnostic Labs
• Brazil Diagnostic Labs Market, By Test Type:
• Pathology
• Radiology
• Brazil Diagnostic Labs Market, By End User:
• Walk-ins
• Referrals
• Corporate Clients
• Brazil Diagnostic Labs Market, By Region

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Brazil Diagnostic Labs Market.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights